Baum RP,Kulkarni HR,Singh A,Kaemmerer D,Mueller D,Prasad V,Hommann M,Robiller FC,Niepsch K,Franz H,Jochems A,Lambin P,Hörsch D P .2018 .Results and adverse events of personalized peptide receptor radionuclide therapy with (90)Yttrium and (177)Lutetium in 1048 patients with neuroendocrine neoplasms. Oncotarget, 9(24) : 16932-16950.
Becker JC,Stang A,DeCaprio JA,Cerroni L,Lebbé C,Veness M,Nghiem P .2017 .Merkel cell carcinoma. Nat. Rev. Dis. Primers, 3 : 17077-17077.
Das T,Bhadwal M,Banerjee S,Sarma HD,Shinto A,Kamaleshwaran KK .2014 .Preparation of DOTATATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application. J. Radioanal. Nucl. Chem, 299(1) : 1389-1398.
Leisser A,Lukic K,Nejabat M,Wadsak W,Mitterhauser M,Mayerhöfer M,Karnaikas G,Raderer M,Hacker M,Haug AR M .2019 .Sex-differences in [68Ga]GaDOTANOC biodistribution. Nucl. Med, : 15-20.
Moriyama S,Takeshita H,Araki S,Tokairin T,Kagawa M,Chiba K,Adachi A,Noro A .2016 .Carcinomalike nonfunctional pheochromocytoma in the right adrenal gland: A case report. Oncol Lett, 12(2) : 1489-1492.
Mueller D,Breeman WAP,Klette I,Gottschaldt M,Odparlik A,Baehre M,Tworowska I,Schultz MK .2016 .Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method. Nat. Protoc, 11(6) : 1057-1066.
Naqvi SAR,Yameen M,Hussain Z,Asim S,Usman M,Khan NH,Abbas K NH .2018 .Enzymatic degradation study of 111In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging radiopharmaceuticals. Pak. J. Pharm. Sci., 31(6 Suppl.) : 2585-2589.
Reubi JC .2003 .) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev., 24(4) : 389-427.
Rizvi SFA,Naqvi SAR,Roohi S,Sherazi TA,Rasheed R .2018 .177Lu-DOTA-coupled minigastrin peptides: promising theranostic agents in neuroendocrine cancers. Mol. Biol. Rep, 45(6) : 1759-1767.
Vis R,Lavalaye R,van de Garde EMW .2015 .GMPcompliant 68Ga radiolabelling in a conventional smallscale radiopharmacy: A feasible approach for routine clinical use. EJNMMI Research, 5 : 27.